Cargando…
A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection
Background: The standard treatment of antibody-mediated rejection (AMR) consists of antilymphocyte antibody, intravenous immunoglobulin, and plasmapheresis. This treatment is associated with a high rate of resistance and refractory AMR. Recent interest has focused on use of rituximab (RTX), a chimer...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Avicenna Organ Transplantation Institute
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089253/ https://www.ncbi.nlm.nih.gov/pubmed/25013595 |